Drugs / AXP1275
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01890161 | Aug 2013 → Apr 2014 | allergic asthma | Axikin Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AXP1275 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01890161 ↗ |
| Route | Oral | “to receive either oral AXP1275 or matching placebo” NCT01890161 ↗ |